Table 1 Patient demographics
|  | Non-diabetic patients (n = 299) | Diabetic patients (n = 89) | |
|---|---|---|---|
Good Glycemic Control (n = 35) | Poor Glycemic Control (n = 54) | ||
Age, median (range) (years) | 52 (24–80) | 52 (28–72) | 52 (26–66) |
Body mass index (kg/m2) | 23.2 (20.0–28.5) | 23.2 (19.4–26.7) | 23.6 (20.8–30.1) |
Serum creatinine, median (range) (μmol/l) | 69 (43–100) | 71 (52–103) | 72 (44–121) |
Smoking status, n (%) | |||
 Never | 278 (93.0) | 33 (94.3) | 51 (94.4) |
 Former | 9 (3.01) | 0 (0.0) | 1 (1.9) |
 Current | 1 (0.3) | 0 (0.0) | 1 (1.9) |
 Missing data | 11 (3.7) | 2 (5.7) | 1 (1.9) |
Regular cervical cancer screening, n (%) | |||
 No | 264 (88.3) | 29 (82.9) | 45 (83.3) |
 Yes | 14 (4.7) | 4 (11.4) | 7 (13.0) |
 Missing data | 21 (7.0) | 2 (5.7) | 2 (3.7) |
Cell type, n (%) | |||
 Squamous cell carcinoma | 253 (84.6) | 30 (85.7) | 41 (75.9) |
 Non-squamous cell carcinoma | 46.0 (15.4) | 5.0 (14.3) | 13.0 (24.1) |
FIGO stage, n (%) | |||
 IB2 | 253 (84.6) | 30 (85.7) | 41 (75.9) |
 IIA2 | 46 (15.4) | 5 (14.3) | 13 (24.1) |
Grade, n (%) | |||
 G1–2 | 274 (91.6) | 33 (94.3) | 49 (90.7) |
 G3 | 25 (8.4) | 2 (5.7) | 5 (9.3) |
Lymph node status, n (%) | |||
 Negative | 202 (67.6) | 17 (48.6) | 28 (51.9) |
 Positive | 97 (32.4) | 18 (51.4) | 26 (48.2) |
Parametrial status, n (%) | |||
 Negative | 291 (97.3) | 33 (94.3) | 50 (92.6) |
 Positive | 8 (2.7) | 2 (5.7) | 4 (7.4) |
Resection margin, n (%) | |||
 Negative | 292 (97.7) | 32 (91.4) | 48 (88.9) |
 Positive | 7 (2.3) | 3 (8.6) | 6 (11.1) |
LVSI, n (%) | |||
 Negative | 156 (52.2) | 18 (51.4) | 26 (48.2) |
 Positive | 143 (47.8) | 17 (48.6) | 28 (51.9) |
Deep stromal invasion, n (%) | |||
 No | 97 (32.4) | 8 (22.9) | 11 (20.4) |
 Yes | 202 (67.6) | 27 (77.1) | 43 (79.6) |
Hypertension, n (%) | |||
 No | 241 (80.6) | 19 (54.3) | 38 (70.4) |
 Yes | 58 (19.4) | 16 (45.7) | 16 (29.6) |
Cardiovascular disease, n (%) | |||
 No | 281 (94.0) | 30 (85.7) | 46 (85.2) |
 Yes | 18 (6.0) | 5 (14.3) | 8 (14.8) |
Metformin use, n (%) | |||
 No | 262 (87.6) | 31 (88.6) | 37 (68.5) |
 Yes | 37 (12.4) | 4 (11.4) | 17 (31.5) |
Complete response, n (%) | |||
 No | 96 (32.1) | 12 (34.3) | 21 (38.9) |
 Yes | 203 (67.9) | 23 (65.7) | 33 (61.1) |